Quick Answer
AVAI BIO, INC. reported Gross Profit of -$40.5 thousand for the year ending 2023.
- AVAI BIO, INC. showed a decrease of -119.2% in Gross Profit from 2022 to 2023.
- This data is from AVAI BIO, INC.'s annual report (Form 10-K), filed with the SEC on July 3, 2024.
- XBRL data for this metric is available from 2019 to 2023 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $0.00 | Q4 2018: $0.00 | Q2 2019: $6.0 thousand | Q3 2019: $0.00 | Q4 2019: $0.00 | Q2 2020: $84.6 thousand | Q3 2020: $87.4 thousand | Q4 2020: $346.2 thousand | Q2 2021: $542.9 thousand | Q3 2021: -$93.4 thousand | Q4 2021: $292.0 thousand | Q2 2022: $24.5 thousand | Q3 2022: $6.6 thousand | Q4 2022: -$71.5 thousand.
- Historical annual values: Fiscal year 2023: -$40.5 thousand | Fiscal year 2022: $210.8 thousand | Fiscal year 2021: -$16.5 thousand | Fiscal year 2020: -$256.3 thousand | Fiscal year 2019: $0.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: